Skip to main content
. 2018 May 14;9:915. doi: 10.3389/fimmu.2018.00915

Figure 2.

Figure 2

Serologic reactivity to phenollic glycolipid-I antigen (PGL-I), LID-1, and ND-O-LID antigens among multibacillary patients from the regular multidrug therapy (R-MDT) and uniform multidrug therapy (U-MDT) groups at different time points MO, M6, M12, and first and second year posttreatment: anti-PGL-I positivity rates in (A) R-MDT group, (B) U-MDT group; anti-LID-1 positivity rates in (C) R-MDT group, (D) U-MDT group; anti-ND-O-LID positivity rates in (E) R-MDT group, (F) U-MDT group. Each point represents the mean optical density (OD) of duplicates of each individual patient. The median OD value of each group is represented by the horizontal line and the traced line represents the different cutoffs (PGL-I OD > 0.25, LID-1 OD > 0.3, and ND-O-LID OD > 0.923). The number above each dataset is the percent of positive responses. The p value refers to differences in positivity rates at different time points.